YuFLiJHuangQCaiH. Increased peripheral blood visfatin concentrations may be a risk marker of coronary artery disease: a meta-analysis of observational studies. Angiology. 2018;69(9):825–34.
2.
ShakerOEl-ShehabyAZakariaA, et al.Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver. Clin Biochem. 2011;44(17-18):1457–63.
3.
FioravantiACheleschiSDe PalmaA, et al.Can adipokines serum levels be used as biomarkers of hand osteoarthritis?Biomarkers. 2018;23(3):265–70.
4.
LeeYHBaeSC. Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis. Int J Rheum Dis. 2018;21(3):664–72.
5.
LuGWWangQJXiaMMQianJ. Elevated plasma visfatin levels correlate with poor prognosis of gastric cancer patients. Peptides. 2014;58:60–4.
6.
BrianaDDBoutsikouMGourgiotisD, et al.Role of visfatin, insulin-like growth factor-I and insulin in fetal growth. J Perinat Med. 2007;35(4):326–9.
AthyrosVGKakafikaAIKaragiannisAMikhailidisDP. Do we need to consider inflammatory markers when we treat atherosclerotic disease?Atherosclerosis. 2008;200(1):1–12.
